Surplus appropriation from R&D and health care technology assessment procedures:
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, Mass.
National Bureau of Economic Research
2006
|
| Schriftenreihe: | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series
12016 |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 22 S. graph. Darst. |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV023591961 | ||
| 003 | DE-604 | ||
| 005 | 20090529 | ||
| 007 | t | ||
| 008 | 060328s2006 xxud||| |||| 00||| eng d | ||
| 035 | |a (OCoLC)64386482 | ||
| 035 | |a (DE-599)BVBBV023591961 | ||
| 040 | |a DE-604 |b ger | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c XD-US | ||
| 049 | |a DE-521 |a DE-19 | ||
| 050 | 0 | |a H11 | |
| 100 | 1 | |a Philipson, Tomas J. |e Verfasser |0 (DE-588)128733101 |4 aut | |
| 245 | 1 | 0 | |a Surplus appropriation from R&D and health care technology assessment procedures |c Tomas J. Philipson ; Anupam B. Jena |
| 264 | 1 | |a Cambridge, Mass. |b National Bureau of Economic Research |c 2006 | |
| 300 | |a 22 S. |b graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 12016 | |
| 650 | 4 | |a Ökonometrisches Modell | |
| 650 | 4 | |a AIDS (Disease) |x Treatment |x Cost effectiveness | |
| 650 | 4 | |a Cost-Benefit Analysis |z United States | |
| 650 | 4 | |a HIV Infections |x economics |z United States | |
| 650 | 4 | |a Health Expenditures |z United States | |
| 650 | 4 | |a Medical care |x Cost effectiveness |x Econometric models | |
| 650 | 4 | |a Medical innovations |x Economic aspects | |
| 650 | 4 | |a Models, Econometric |z United States | |
| 650 | 4 | |a Research |z United States | |
| 650 | 4 | |a Technology Assessment, Biomedical |x economics |z United States | |
| 651 | 4 | |a USA | |
| 700 | 1 | |a Jena, Anupam B. |e Verfasser |0 (DE-588)131548751 |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |
| 830 | 0 | |a National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |v 12016 |w (DE-604)BV002801238 |9 12016 | |
| 856 | 4 | 1 | |u http://papers.nber.org/papers/w12016.pdf |z kostenfrei |3 Volltext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016907291 | ||
Datensatz im Suchindex
| _version_ | 1804138249938010112 |
|---|---|
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author | Philipson, Tomas J. Jena, Anupam B. |
| author_GND | (DE-588)128733101 (DE-588)131548751 |
| author_facet | Philipson, Tomas J. Jena, Anupam B. |
| author_role | aut aut |
| author_sort | Philipson, Tomas J. |
| author_variant | t j p tj tjp a b j ab abj |
| building | Verbundindex |
| bvnumber | BV023591961 |
| callnumber-first | H - Social Science |
| callnumber-label | H11 |
| callnumber-raw | H11 |
| callnumber-search | H11 |
| callnumber-sort | H 211 |
| callnumber-subject | H - Social Science |
| ctrlnum | (OCoLC)64386482 (DE-599)BVBBV023591961 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01833nam a2200457zcb4500</leader><controlfield tag="001">BV023591961</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090529 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">060328s2006 xxud||| |||| 00||| eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)64386482</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV023591961</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">XD-US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-521</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">H11</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Philipson, Tomas J.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)128733101</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Surplus appropriation from R&D and health care technology assessment procedures</subfield><subfield code="c">Tomas J. Philipson ; Anupam B. Jena</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, Mass.</subfield><subfield code="b">National Bureau of Economic Research</subfield><subfield code="c">2006</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">22 S.</subfield><subfield code="b">graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">12016</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Ökonometrisches Modell</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">AIDS (Disease)</subfield><subfield code="x">Treatment</subfield><subfield code="x">Cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cost-Benefit Analysis</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">HIV Infections</subfield><subfield code="x">economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Health Expenditures</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical care</subfield><subfield code="x">Cost effectiveness</subfield><subfield code="x">Econometric models</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medical innovations</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Models, Econometric</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Research</subfield><subfield code="z">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Technology Assessment, Biomedical</subfield><subfield code="x">economics</subfield><subfield code="z">United States</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jena, Anupam B.</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)131548751</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series</subfield><subfield code="v">12016</subfield><subfield code="w">(DE-604)BV002801238</subfield><subfield code="9">12016</subfield></datafield><datafield tag="856" ind1="4" ind2="1"><subfield code="u">http://papers.nber.org/papers/w12016.pdf</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016907291</subfield></datafield></record></collection> |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV023591961 |
| illustrated | Illustrated |
| index_date | 2024-07-02T22:41:29Z |
| indexdate | 2024-07-09T21:25:12Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016907291 |
| oclc_num | 64386482 |
| open_access_boolean | 1 |
| owner | DE-521 DE-19 DE-BY-UBM |
| owner_facet | DE-521 DE-19 DE-BY-UBM |
| physical | 22 S. graph. Darst. |
| publishDate | 2006 |
| publishDateSearch | 2006 |
| publishDateSort | 2006 |
| publisher | National Bureau of Economic Research |
| record_format | marc |
| series | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| series2 | National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series |
| spelling | Philipson, Tomas J. Verfasser (DE-588)128733101 aut Surplus appropriation from R&D and health care technology assessment procedures Tomas J. Philipson ; Anupam B. Jena Cambridge, Mass. National Bureau of Economic Research 2006 22 S. graph. Darst. txt rdacontent n rdamedia nc rdacarrier National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 12016 Ökonometrisches Modell AIDS (Disease) Treatment Cost effectiveness Cost-Benefit Analysis United States HIV Infections economics United States Health Expenditures United States Medical care Cost effectiveness Econometric models Medical innovations Economic aspects Models, Econometric United States Research United States Technology Assessment, Biomedical economics United States USA Jena, Anupam B. Verfasser (DE-588)131548751 aut Erscheint auch als Online-Ausgabe National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series 12016 (DE-604)BV002801238 12016 http://papers.nber.org/papers/w12016.pdf kostenfrei Volltext |
| spellingShingle | Philipson, Tomas J. Jena, Anupam B. Surplus appropriation from R&D and health care technology assessment procedures National Bureau of Economic Research <Cambridge, Mass.>: NBER working paper series Ökonometrisches Modell AIDS (Disease) Treatment Cost effectiveness Cost-Benefit Analysis United States HIV Infections economics United States Health Expenditures United States Medical care Cost effectiveness Econometric models Medical innovations Economic aspects Models, Econometric United States Research United States Technology Assessment, Biomedical economics United States |
| title | Surplus appropriation from R&D and health care technology assessment procedures |
| title_auth | Surplus appropriation from R&D and health care technology assessment procedures |
| title_exact_search | Surplus appropriation from R&D and health care technology assessment procedures |
| title_exact_search_txtP | Surplus appropriation from R&D and health care technology assessment procedures |
| title_full | Surplus appropriation from R&D and health care technology assessment procedures Tomas J. Philipson ; Anupam B. Jena |
| title_fullStr | Surplus appropriation from R&D and health care technology assessment procedures Tomas J. Philipson ; Anupam B. Jena |
| title_full_unstemmed | Surplus appropriation from R&D and health care technology assessment procedures Tomas J. Philipson ; Anupam B. Jena |
| title_short | Surplus appropriation from R&D and health care technology assessment procedures |
| title_sort | surplus appropriation from r d and health care technology assessment procedures |
| topic | Ökonometrisches Modell AIDS (Disease) Treatment Cost effectiveness Cost-Benefit Analysis United States HIV Infections economics United States Health Expenditures United States Medical care Cost effectiveness Econometric models Medical innovations Economic aspects Models, Econometric United States Research United States Technology Assessment, Biomedical economics United States |
| topic_facet | Ökonometrisches Modell AIDS (Disease) Treatment Cost effectiveness Cost-Benefit Analysis United States HIV Infections economics United States Health Expenditures United States Medical care Cost effectiveness Econometric models Medical innovations Economic aspects Models, Econometric United States Research United States Technology Assessment, Biomedical economics United States USA |
| url | http://papers.nber.org/papers/w12016.pdf |
| volume_link | (DE-604)BV002801238 |
| work_keys_str_mv | AT philipsontomasj surplusappropriationfromrdandhealthcaretechnologyassessmentprocedures AT jenaanupamb surplusappropriationfromrdandhealthcaretechnologyassessmentprocedures |